Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10339 | 31384519 | Biosci Microbiota Food Health | The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. | 2019 | Details |
| A10343 | 31381969 | J Steroid Biochem Mol Biol | Understanding the association of polycystic ovary syndrome and non-alcoholic fatty liver disease. | 2019 | Details |
| A10349 | 31379820 | Front Immunol | Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond. | 2019 | Details |
| A10354 | 31378768 | J Toxicol Sci | Immunohistochemical expression of autophagosome markers LC3 and p62 in preneoplastic liver foci in high fat diet-fed rats. | 2019 | Details |
| A10362 | 31374827 | Medicines (Basel) | Perspectives on Interval Exercise Interventions for Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10366 | 31372873 | Obes Surg | Laparoscopic Sleeve Gastrectomy on the Horizon as a Promising Treatment Modality for NAFLD. | 2020 | Details |
| A10369 | 31372020 | Diabetes Metab Syndr Obes | Abdominal subcutaneous fat thickness and homeostasis model assessment of insulin resistance as simple predictors of nonalcoholic steatohepatitis. | 2019 | Details |
| A10370 | 31371265 | Nutr Metab Cardiovasc Dis | Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype. | 2019 | Details |
| A10373 | 31367159 | World J Gastroenterol | Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis via gut microbiota. | 2019 | Details |
| A10375 | 31366865 | Biol Pharm Bull | Cranberry Attenuates Progression of Non-alcoholic Fatty Liver Disease Induced by High-Fat Diet in Mice. | 2019 | Details |
| A10377 | 31366455 | Gut | Epidemiology of chronic liver diseases in the USA in the past three decades. | 2019 | Details |
| A10384 | 31361524 | FASEB J | Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway. | 2019 | Details |
| A10386 | 31360108 | Int J Biol Sci | Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer. | 2019 | Details |
| A10390 | 31359195 | Surg Endosc | Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease. | 2019 | Details |
| A10394 | 31357643 | Int J Mol Sci | Association between Lysosomal Dysfunction and Obesity-Related Pathology: A Key Knowledge to Prevent Metabolic Syndrome. | 2019 | Details |
| A10400 | 31354322 | Diabetes Metab Syndr Obes | Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women. | 2019 | Details |
| A10411 | 31347138 | Infection | Epidemiological and etiological variations in hepatocellular carcinoma. | 2019 | Details |
| A10414 | 31345776 | Lancet Diabetes Endocrinol | Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study. | 2019 | Details |
| A10419 | 31343128 | Pediatr Endocrinol Diabetes Metab | Usefulness of the metabolic syndrome diagnosis in obese children in clinical practice. | 2019 | Details |
| A10420 | 31343116 | Obesity (Silver Spring) | Novel Strategies to Treat Hepatic Steatosis and Steatohepatitis. | 2019 | Details |
| A10422 | 31342672 | Obes Rev | A systematic review and meta-analysis estimating the population prevalence of comorbidities in children and adolescents aged 5 to 18 years. | 2019 | Details |
| A10424 | 31341886 | Biomed Res Int | Sex, Age, and BMI Modulate the Association of Physical Examinations and Blood Biochemistry Parameters and NAFLD: A Retrospective Study on 1994 Cases Observed at Shuguang Hospital, China. | 2019 | Details |
| A10425 | 31341532 | Oxid Med Cell Longev | Dietary Glycotoxins Impair Hepatic Lipidemic Profile in Diet-Induced Obese Rats Causing Hepatic Oxidative Stress and Insulin Resistance. | 2019 | Details |
| A10426 | 31341444 | Integr Med (Encinitas) | Non-Alcoholic Fatty Liver Disease, an Overview. | 2019 | Details |
| A10428 | 31341404 | Int J Med Sci | Possible association of arrestin domain-containing protein 3 and progression of non-alcoholic fatty liver disease. | 2019 | Details |
| A10430 | 31338830 | Eur J Clin Invest | Nonalcoholic fatty liver disease increases the risk of gastroesophageal reflux disease: A systematic review and meta-analysis. | 2019 | Details |
| A10436 | 31336557 | Diabetes Metab Syndr | Effect of diet-induced weight loss on cytokeratin-18 levels in overweight and obese patients with liver fibrosis. | 2019 | Details |
| A10437 | 31336526 | Diabetes Metab Syndr | Prevalence of non-alcoholic fatty liver disease in patients with diabetes mellitus, hyperlipidemia, obesity and polycystic ovary syndrome: A cross-sectional study in north of Iran. | 2019 | Details |
| A10438 | 31336502 | Diabetes Metab Syndr | The influence of insulin resistance in the occurence of non-alcoholic fatty liver disease among first degree relatives of type 2 diabetes. | 2019 | Details |
| A10439 | 31336476 | Diabetes Metab Syndr | Nutrition and physical activity in Asian Indians with non-alcoholic fatty liver: A case control study. | 2019 | Details |
| A10442 | 31336149 | Biochim Biophys Acta Mol Basis Dis | The adipokine sFRP4 induces insulin resistance and lipogenesis in the liver. | 2019 | Details |
| A10448 | 31333877 | Clin Diabetes Endocrinol | Natural history of ROHHAD syndrome: development of severe insulin resistance and fatty liver disease over time. | 2019 | Details |
| A10451 | 31332389 | Nat Med | Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. | 2019 | Details |
| A10456 | 31330134 | Metabolism | AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease. | 2019 | Details |
| A10457 | 31328300 | Aliment Pharmacol Ther | Depression is associated with non-alcoholic fatty liver disease among adults in the United States. | 2019 | Details |
| A10461 | 31326267 | J Diabetes Complications | Increased risk of non-alcoholic fatty liver disease in women with gestational diabetes mellitus: A population-based cohort study, systematic review and meta-analysis. | 2019 | Details |
| A10467 | 31324878 | Int J Obes (Lond) | Role of ghrelin isoforms in the mitigation of hepatic inflammation, mitochondrial dysfunction, and endoplasmic reticulum stress after bariatric surgery in rats. | 2019 | Details |
| A10472 | 31322445 | Scand J Gastroenterol | Transient elastography: should XL probe be used in all overweight patients? | 2019 | Details |
| A10475 | 31322211 | Mol Med Rep | Ascorbic acid attenuates cell stress by activating the fibroblast growth factor 21/fibroblast growth factor receptor 2/adiponectin pathway in HepG2 cells. | 2019 | Details |
| A10476 | 31321014 | Ther Adv Chronic Dis | Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus. | 2019 | Details |
| A10478 | 31319896 | Clin Epigenetics | Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome. | 2019 | Details |
| A10486 | 31315613 | BMC Endocr Disord | The relationship between non-alcoholic fatty liver and skeletal muscle mass to visceral fat area ratio in women with type 2 diabetes. | 2019 | Details |
| A10487 | 31315327 | J Assoc Physicians India | Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease. | 2018 | Details |
| A10492 | 31312990 | Dig Dis Sci | Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges. | 2019 | Details |
| A10502 | 31309820 | Curr Vasc Pharmacol | Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review. | 2019 | Details |
| A10510 | 31308634 | Drug Des Devel Ther | The protective effect and mechanism of the FXR agonist obeticholic acid via targeting gut microbiota in non-alcoholic fatty liver disease. | 2019 | Details |
| A10513 | 31307925 | Obes Res Clin Pract | Nonalcoholic fatty liver disease does not predict worse perioperative outcomes in bariatric surgery. | 2019 | Details |
| A10514 | 31307592 | Adv Pharmacol | Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. | 2019 | Details |
| A10520 | 31304703 | J Assoc Physicians India | Association of Genetic Non-alcoholic Fatty Liver Disease with Insulin Resistance-Are we Different? | 2019 | Details |
| A10521 | 31304450 | Hepatol Commun | Selective Liver Estrogen Receptor α Modulation Prevents Steatosis, Diabetes, and Obesity Through the Anorectic Growth Differentiation Factor 15 Hepatokine in Mice. | 2019 | Details |
| A10522 | 31303681 | J Okla State Med Assoc | Overview of Pediatric Nonalcoholic Fatty Liver Disease: A Guide for General Practitioners. | 2018 | Details |
| A10525 | 31301321 | J Hepatol | Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease. | 2019 | Details |
| A10532 | 31299271 | Toxicol Appl Pharmacol | IFN-α-2b treatment protects against diet-induced obesity and alleviates non-alcoholic fatty liver disease in mice. | 2019 | Details |
| A10535 | 31298151 | Curr Pharm Des | Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus. | 2019 | Details |
| A10538 | 31295962 | J Clin Med | Independent Association of Physical Activity with Nonalcoholic Fatty Liver Disease and Alanine Aminotransferase Levels. | 2019 | Details |
| A10542 | 31293908 | J Clin Transl Hepatol | Association between NAFLD and Risk of Colorectal Adenoma in Chinese Han Population. | 2019 | Details |
| A10547 | 31293337 | World J Gastroenterol | Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. | 2019 | Details |
| A10551 | 31292564 | Nat Rev Rheumatol | Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions. | 2019 | Details |
| A10555 | 31292134 | Diabetes | Osteoprotegerin Promotes Liver Steatosis by Targeting the ERK-PPAR-γ-CD36 Pathway. | 2019 | Details |
| A10558 | 31291052 | Diabetes Metab Res Rev | Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population. | 2019 | Details |
| A10560 | 31290748 | Turk J Gastroenterol | Association of obesity with chronic kidney disease in elderly patients with nonalcoholic fatty liver disease. | 2019 | Details |
| A10564 | 31289229 | Proc Natl Acad Sci U S A | YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity. | 2019 | Details |
| A10567 | 31288346 | Zhonghua Yu Fang Yi Xue Za Zhi | [Childhood obesity and early target organ damage]. | 2019 | Details |
| A10568 | 31288283 | Z Gastroenterol | [Microbiome & NASH - partners in crime driving progression of fatty liver disease]. | 2019 | Details |
| A10570 | 31284753 | FASEB J | Hepatic PEMT activity mediates liver health, weight gain, and insulin resistance. | 2019 | Details |
| A10571 | 31284538 | Molecules | The Modulatory Action of Vitamin D on the Renin-Angiotensin System and the Determination of Hepatic Insulin Resistance. | 2019 | Details |
| A10575 | 31283527 | Eur J Gastroenterol Hepatol | Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases. | 2020 | Details |
| A10580 | 31281460 | Exp Ther Med | Aged garlic extract ameliorates fatty liver and insulin resistance and improves the gut microbiota profile in a mouse model of insulin resistance. | 2019 | Details |
| A10584 | 31280506 | Isr Med Assoc J | Non-alcoholic Fatty Liver Disease is Associated with Recurrent Urinary Tract Infection in Premenopausal Women Independent of Metabolic Syndrome. | 2019 | Details |
| A10587 | 31279904 | J Hepatol | Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease. | 2019 | Details |
| A10588 | 31279902 | J Hepatol | The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis. | 2019 | Details |
| A10589 | 31279739 | Metabolism | Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. | 2019 | Details |
| A10591 | 31278754 | J Physiol | Liver sympathetic denervation reverses obesity-induced hepatic steatosis. | 2019 | Details |
| A10597 | 31275587 | BMJ Open Gastroenterol | Non-alcoholic fatty liver disease with obesity as an independent predictor for incident gastric and colorectal cancer: a population-based longitudinal study. | 2019 | Details |
| A10601 | 31275407 | Evid Based Complement Alternat Med | Pharmacological Activities of Alisma orientale against Nonalcoholic Fatty Liver Disease and Metabolic Syndrome: Literature Review. | 2019 | Details |
| A10604 | 31274482 | Asian J Androl | Histologically proven hepatic steatosis associates with lower testosterone levels in men with obesity. | 2021 | Details |
| A10607 | 31273617 | Hepatol Int | Hepatology through the crystal ball. | 2019 | Details |
| A10608 | 31273595 | Dig Dis Sci | Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China. | 2019 | Details |
| A10619 | 31269758 | Mar Drugs | Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice. | 2019 | Details |
| A10623 | 31266893 | Proc Natl Acad Sci U S A | p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicity. | 2019 | Details |
| A10624 | 31266632 | Biochem Biophys Res Commun | Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice. | 2019 | Details |
| A10636 | 31260143 | J Gastroenterol Hepatol | Genetic and lifestyle risk factors for advanced liver disease among men and women. | 2019 | Details |
| A10637 | 31260026 | JAMA Intern Med | Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. | 2019 | Details |
| A10640 | 31258138 | Turk J Gastroenterol | Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience. | 2019 | Details |
| A10641 | 31258135 | Turk J Gastroenterol | Non-alcoholic fatty liver disease: A growing public health problem in Turkey. | 2019 | Details |
| A10644 | 31256424 | J Cell Physiol | microRNA-141 is associated with hepatic steatosis by downregulating the sirtuin1/AMP-activated protein kinase pathway in hepatocytes. | 2019 | Details |
| A10646 | 31255807 | Clin Gastroenterol Hepatol | Combined Effects of Alcohol and Metabolic Disorders in Patients With Chronic Liver Disease. | 2019 | Details |
| A10647 | 31255652 | Gastroenterology | Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10648 | 31255630 | Dig Liver Dis | Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescents. | 2019 | Details |
| A10658 | 31251092 | Curr Med Res Opin | Phenotypic characteristics and risk factors in a multi-ethnic cohort of young adults with type 2 diabetes. | 2019 | Details |
| A10660 | 31250467 | Aliment Pharmacol Ther | The PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng Study. | 2019 | Details |
| A10662 | 31246368 | Aliment Pharmacol Ther | Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. | 2019 | Details |
| A10663 | 31246081 | Eur J Paediatr Dent | The sweet danger of added sugars. | 2019 | Details |
| A10664 | 31245932 | Obesity (Silver Spring) | Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study. | 2019 | Details |
| A10667 | 31245168 | Liver Res | Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. | 2018 | Details |
| A10674 | 31241820 | Liver Int | Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs. | 2019 | Details |
| A10685 | 31236880 | Bull Exp Biol Med | Effect of Linagliptin on the Ratio of Apoptosis Regulators in the Model of Non-Alcoholic Fatty Liver Disease in db/db Mice. | 2019 | Details |
| A10689 | 31235166 | Diabetes Metab Syndr | A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10691 | 31235092 | Diabetes Metab Syndr | Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. | 2019 | Details |
| A10700 | 31232044 | Clin Lab | Association between Serum Ferritin Level and Nonalcoholic Fatty Liver Disease in a Non-Obese Chinese Population: a Cross-Sectional Study. | 2019 | Details |